Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 6
1954 3
1956 2
1957 5
1958 1
1959 1
1964 2
1965 6
1966 11
1967 13
1968 20
1969 11
1970 17
1971 11
1972 24
1973 16
1974 12
1975 16
1976 21
1977 16
1978 16
1979 17
1980 22
1981 23
1982 22
1983 17
1984 20
1985 25
1986 15
1987 12
1988 17
1989 15
1990 22
1991 15
1992 18
1993 20
1994 18
1995 27
1996 19
1997 29
1998 15
1999 22
2000 30
2001 41
2002 36
2003 36
2004 35
2005 30
2006 33
2007 29
2008 40
2009 37
2010 59
2011 53
2012 49
2013 52
2014 45
2015 42
2016 47
2017 49
2018 56
2019 49
2020 56
2021 36
2022 51
2023 43
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

1,572 results

Results by year

Filters applied: . Clear all
Page 1
Congenital adrenal hyperplasia.
Auer MK, Nordenström A, Lajic S, Reisch N. Auer MK, et al. Lancet. 2023 Jan 21;401(10372):227-244. doi: 10.1016/S0140-6736(22)01330-7. Epub 2022 Dec 8. Lancet. 2023. PMID: 36502822 Review.
Congenital adrenal hyperplasia is a group of autosomal recessive disorders leading to multiple complex hormonal imbalances caused by various enzyme deficiencies in the adrenal steroidogenic pathway. The most common type of congenital adrenal hyperplasia …
Congenital adrenal hyperplasia is a group of autosomal recessive disorders leading to multiple complex hormonal imbalances cau …
Management challenges and therapeutic advances in congenital adrenal hyperplasia.
Mallappa A, Merke DP. Mallappa A, et al. Nat Rev Endocrinol. 2022 Jun;18(6):337-352. doi: 10.1038/s41574-022-00655-w. Epub 2022 Apr 11. Nat Rev Endocrinol. 2022. PMID: 35411073 Free PMC article. Review.
Treatment for congenital adrenal hyperplasia (CAH) was introduced in the 1950s following the discovery of the structure and function of adrenocortical hormones. ...Management is complicated by a combination of comorbidities that arise from disease-related hormonal d …
Treatment for congenital adrenal hyperplasia (CAH) was introduced in the 1950s following the discovery of the structure and fu …
Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia.
Merke DP, Mallappa A, Arlt W, Brac de la Perriere A, Lindén Hirschberg A, Juul A, Newell-Price J, Perry CG, Prete A, Rees DA, Reisch N, Stikkelbroeck N, Touraine P, Maltby K, Treasure FP, Porter J, Ross RJ. Merke DP, et al. J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2063-e2077. doi: 10.1210/clinem/dgab051. J Clin Endocrinol Metab. 2021. PMID: 33527139 Free PMC article. Clinical Trial.
CONTEXT: Standard glucocorticoid therapy in congenital adrenal hyperplasia (CAH) regularly fails to control androgen excess, causing glucocorticoid overexposure and poor health outcomes. OBJECTIVE: We investigated whether modified-release hydrocortisone (MR-HC), whi …
CONTEXT: Standard glucocorticoid therapy in congenital adrenal hyperplasia (CAH) regularly fails to control androgen excess, c …
Challenges in treatment of patients with non-classic congenital adrenal hyperplasia.
Adriaansen BPH, Schröder MAM, Span PN, Sweep FCGJ, van Herwaarden AE, Claahsen-van der Grinten HL. Adriaansen BPH, et al. Front Endocrinol (Lausanne). 2022 Dec 12;13:1064024. doi: 10.3389/fendo.2022.1064024. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36578966 Free PMC article. Review.
Congenital adrenal hyperplasia (CAH) due to 21alpha-hydroxylase deficiency (21OHD) or 11beta-hydroxylase deficiency (11OHD) are congenital conditions with affected adrenal steroidogenesis. ...
Congenital adrenal hyperplasia (CAH) due to 21alpha-hydroxylase deficiency (21OHD) or 11beta-hydroxylase deficiency (11OHD) ar …
Crinecerfont Lowers Elevated Hormone Markers in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia.
Auchus RJ, Sarafoglou K, Fechner PY, Vogiatzi MG, Imel EA, Davis SM, Giri N, Sturgeon J, Roberts E, Chan JL, Farber RH. Auchus RJ, et al. J Clin Endocrinol Metab. 2022 Feb 17;107(3):801-812. doi: 10.1210/clinem/dgab749. J Clin Endocrinol Metab. 2022. PMID: 34653252 Free PMC article. Clinical Trial.
CONTEXT: Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21OHD) is characterized by impaired cortisol synthesis and excess androgen production. ...Longer-term studies are required to evaluate the effects of crinecerfont on clinical en …
CONTEXT: Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21OHD) is characterized by impaired cortisol …
Congenital Adrenal Hyperplasia.
Fraga NR, Minaeian N, Kim MS. Fraga NR, et al. Pediatr Rev. 2024 Feb 1;45(2):74-84. doi: 10.1542/pir.2022-005617. Pediatr Rev. 2024. PMID: 38296783 Review.
We describe congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, which is the most common primary adrenal insufficiency in children and adolescents. ...
We describe congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, which is the most common primary adrenal in …
Congenital adrenal hyperplasia: New biomarkers and adult treatments.
Dreves B, Reznik Y, Tabarin A. Dreves B, et al. Ann Endocrinol (Paris). 2023 Aug;84(4):472-480. doi: 10.1016/j.ando.2023.01.008. Epub 2023 Feb 25. Ann Endocrinol (Paris). 2023. PMID: 36842612 Review.
Congenital adrenal hyperplasia (CAH) is a genetic disease caused by an enzyme deficiency interrupting adrenal steroidogenesis. ...Optimizing the management of these patients first involves using more specific biomarkers of adrenal steroidogenesis in difficult situat …
Congenital adrenal hyperplasia (CAH) is a genetic disease caused by an enzyme deficiency interrupting adrenal steroidogenesis. …
Classic congenital adrenal hyperplasia.
Nermoen I, Husebye ES, Myhre AG, Løvås K. Nermoen I, et al. Tidsskr Nor Laegeforen. 2017 Apr 4;137(7):540-543. doi: 10.4045/tidsskr.16.0376. eCollection 2017 Apr. Tidsskr Nor Laegeforen. 2017. PMID: 28383228 Free article. Review. English, Norwegian.
Congenital adrenal hyperplasia is attributed to inherited enzyme defects in the adrenal cortex. ...This causes virilisation in girls, adrenocortical failure and early puberty in both sexes. This article describes the genetics, clinical picture, diagnostics an …
Congenital adrenal hyperplasia is attributed to inherited enzyme defects in the adrenal cortex. ...This causes virilisation in …
Current and future perspectives on clinical management of classic 21-hydroxylase deficiency.
Yogi A, Kashimada K. Yogi A, et al. Endocr J. 2023 Oct 30;70(10):945-957. doi: 10.1507/endocrj.EJ23-0075. Epub 2023 Jun 29. Endocr J. 2023. PMID: 37380491 Free article. Review.
In this review, we aimed to comprehensively summarize the current status of classic 21OHD treatment, including the initial treatment during the neonatal period, management of adrenal insufficiency, maintenance therapy of each life stage, and the importance of clinical mana …
In this review, we aimed to comprehensively summarize the current status of classic 21OHD treatment, including the initial treatment during …
Pregnancy in Congenital Adrenal Hyperplasia.
Reisch N. Reisch N. Endocrinol Metab Clin North Am. 2019 Sep;48(3):619-641. doi: 10.1016/j.ecl.2019.05.011. Endocrinol Metab Clin North Am. 2019. PMID: 31345527 Review.
Fertility rates in classic congenital adrenal hyperplasia caused by 21-hydroxylase deficiency are substantially decreased for various reasons, including hormonal, anatomic, psychosocial, and psychosexual causes. ...In nonclassic 21-hydroxylase deficiency, preconcept …
Fertility rates in classic congenital adrenal hyperplasia caused by 21-hydroxylase deficiency are substantially decreased for …
1,572 results